Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-06-03 00:00:00 ET · period of report 2024-05-31 · accession 0001127602-24-017329 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-03 | 2024-05-31 | CYTK | Lee Sung | EVP, CFO | A - Grant | $0.00 | +34.7K | 34.7K | New | $0 |
| D | 2024-06-03 | 2024-05-31 | CYTK | Lee Sung | EVP, CFO | A - Grant | $0.00 | +53.4K | 53.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-31 | A | A | 34,684 | $0.00 | 34,684 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-05-31 | A | A | 53,417 | $0.00 | 53,417 | D | $48.51 · 2025-06-02 to 2034-05-30 | 53,417 Common Stock |